Individuals’ pursuit for everlasting wellness will be at the center of the future health ecosystem. The consumer will receive care whenever and wherever he or she goes.
The delivery of goods and services in the health sector is changing dramatically. This is due to a shift away from episodic sick care and toward an emphasis on wellness and disease prevention, as well as increasing customer expectations for increased convenience, flexibility, and “anytime, anywhere” health care.
A confluence of non-health businesses is entering and redefining the health arena to fulfill this new delivery model demand. Weekly announcements of new acquisitions, mergers, or partnerships between and across industries are common, with seemingly unrelated organizations banding together to focus on health.
All of this adds up to significant — and mainly positive — shifts in the health supply chain and logistics industry – MHRA approved warehousing UK. Meeting new delivery expectations and figuring out how atypical enterprises will interact increases the value of supply chain and logistics organizations in providing health care to consumers.
Future supply chain and logistics champions will build end-to-end, multimodal delivery networks that include all stakeholders, including clinicians, pharmaceutical and biotechnology partners, lab companies, payers, technology and data analytics firms, and, of course, wellness and health consumers (along with their family members).
Three critical considerations for supply chain firms
1. Supply chain companies are an important aspect of the decentralized health concept, providing tailored, quick care wherever.
Moving upstream of delivery and logistics may be the only way to compete with the juggernauts of online retail when the consumer is at the center of a vortex of items and offerings and care is just a delivery away.
• Health is becoming more interconnected, and care will be offered almost anywhere, to patients regardless of their physical location. This ambition is being realized through the creation of care platforms. Patients can obtain non-emergency drugs for baldness, erectile dysfunction, birth control, and other purposes immediately from their computers or phones, thanks to new technology that are enabling the rise of health care. Companies are avoiding medication supply chain intermediaries and lowering doctor visits by simplifying prescribing and delivering drugs directly to patients, resulting in new patterns in pharmaceutical distribution.
• Patients expect same-day delivery and on-demand access in health care, just as they do in media and retail. Inventive solutions for direct-to-consumer deliveries with a more flexible and swifter last-mile process can be found in supply chain businesses, requiring creative solutions for direct-to-consumer deliveries with a more flexible and speedier last-mile process.
• Consumers are increasingly demanding tailored health products and services, and the industry is responding. Health and life sciences companies are engaging in research to learn what motivates people’s actions, how different engagement styles differ, and how risk and uncertainty tolerance affect the success of various communications. For example, firms are looking into ways to make DNA sequencing more accessible for consumers, potentially paving the way for genuinely individualized diagnostics and therapy that might vastly improve patient outcomes for a variety of diseases.
2. The major drivers for simplifying supply chain processes are data, predictive analytics, and contextually relevant insights.
Supply chain organizations will succeed if they can combine the ability to become brutally efficient in today’s industry while also establishing capabilities for a consumer-centric, decentralized, and data-driven future — and do so faster than their competitors in other industries.
• The goal is for supply chain stakeholders to achieve zero waste just-in-time delivery and enable track-and-trace capabilities that generate an auditable data trail. This is necessary to support the claims that are required in any value-based payment model, and attaining it positions supply chain firms as powerful partners for providers, pharmaceutical companies, and payers.
• The engine of future growth will be data. Converging traditional and nontraditional businesses by combining health-care experience with network and platform skills is proven to be a significant sort of convergence. In truth, most of what affects one’s health occurs outside of the realm of medicine. Integrating clinical and nonclinical data (lifestyle, environmental, genetic, etc.) facilitated by mobile connectivity, low-cost cloud storage, wearable and durable environmental sensors, and portable medical devices will provide true value to health consumers. Across the supply chain, zettabytes of data are already being collected, and 750 quadrillion bytes of health care data are generated every day.
• Supply chain firms will be able to help clients cut through the noise as new types of data — and significantly more of it — become available. Health stakeholders, such as drug makers, providers, and payers, would benefit greatly from the information highway that runs alongside the supply chain. The supply chain industry might rebuild itself around the empowered patient-consumer if it harnessed the value of this data. Predictive analytics and algorithms, as well as robotic process automation, blockchain, and 3D printing, are critical components of the solution, offering a holistic perspective of a patient’s health and logistics demands.
3. A secure and efficient supply chain is required
Companies must prepare to manage cybersecurity concerns as the proliferation of data and use of digital technology grows throughout the health-care supply chain. There will be more weak entry points as more sensors and devices link to health and wellness platforms.
• The importance of data security will climb to unprecedented heights. Cyber-attacks can be prevented by treating them as a serious company issue and putting in place adequate security and privacy policies. Supply chain and logistics firms must maintain a focus on both safeguarding current operations and building a sound prevention and cybersecurity plan to address emerging risks as business models in the health logistics industry grow.
• The importance of connectivity cannot be overstated. Consumers are more connected than ever before, and the Internet of Things is making inroads into the healthcare industry. A health platform strategy must be able to collect, aggregate, and analyze data generated by emerging technologies in order to provide meaningful insights to consumers and health enterprises.
• The importance of data to efficiency and effectiveness cannot be overstated. Not only must logistics businesses deliver the correct product to the correct patient at the correct time, in the correct dose, and via the correct route, but they must also track, trace, and prove it. Detailed data on supply chain shipments, usage and returns, claims, and clinical outcomes are captured and analyzed to offer real-world evidence of product efficacy. This entails tighter inventory and delivery control, as well as better control during transit and visibility throughout the distribution chain.